qPCR analyses confirmed the integration of the EGFP/PGK‐FANCA cassette both in the BM and in the spleen of these mice (data not shown), demonstrating the feasibility of targeting a therapeutic FA donor in the AAVS1 site of HD HSPCs characterized by in vivo repopulating properties. This evidence concerns the gene FANCA and Huntington disease.